-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Upgrades Edwards Lifesciences to Overweight, Raises Price Target to $80

Benzinga·04/24/2025 11:13:55
Listen to the news
Piper Sandler analyst Adam Maeder upgrades Edwards Lifesciences (NYSE:EW) from Neutral to Overweight and raises the price target from $73 to $80.